New York, February 20, 2018 – Non-profit pharmaceutical industry organization New York Pharma Forum (NYPF), announced it will bring leading Japanese scientists to the US for a “Japan Life Sciences Showcase” on March 13th and 14th to explore partnering opportunities with biopharma companies and institutions. The program will be co-hosted by the Japan Agency for Medical Research and Development (AMED), a Japanese government agency.
New York Pharma Forum to Hold "Japan Life Sciences Showcase" - Leading Japanese Scientists Explore Partnering Opportunities in the US
Posted by Elisabeth DellaMonica on Feb 20, 2018 11:22:49 AM
Topics: Clinical Trials, innovation, healthcare, pharma, news, pharmaceutical, new york, global health
Background on and Trends in Ethnic Bridging Studies
Posted by New York Pharma Forum Inc. on May 28, 2014 11:14:00 AM
An ethnic group is defined as a group of people who identify with each other based on intrinsic factors, such as genetic similarities due to common ancestry, and extrinsic factors, such as shared cultural experiences or environment. Therefore, one’s ethnicity is a fundamental aspect of life that defines a person, and that differentiates that person from others.
Ethnic differences have become important in the field of clinical drug development because they may impact the absorption, distribution, metabolism, or excretion (ADME) of drugs, and may be relevant to an understanding of a drug’s efficacy and safety.
Topics: patent law, Clinical Trials